SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

GIB Gibb River Diamonds Limited

Basic Materials · Other Precious Metals & Mining · website
$0.03
52wk 0.03 – 0.08
Overall
59.3
Value
62.5
Growth
—
Health
100.0
Quality
54.5
Momentum
5.5
Dividend
—
Price
About Gibb River Diamonds Limited

Gibb River Diamonds Limited engages in the mineral exploration business. The company explores for diamond, gold, uranium, phosphate, zinc, and lead deposits. The company was formerly known as POZ Minerals Limited and changed its name to Gibb River Diamonds Limited in November 2018. Gibb River Diamonds Limited was incorporated in 2008 and is based in West Perth, Australia.

Commodity exposure

Primary exposure: Gold (detected from the company profile: gold)

Gold primary
4,213.80 USD/oz
1m: -3.5% · 1y: 9.7%
Uranium (URA ETF proxy)
39.59 USD (ETF)
1m: -9.9% · 1y: -18.0%
Zinc
No direct price series on Yahoo Finance
Price analytics

Returns

1 day 0.0%
1 week -8.8%
1 month -6.1%
3 months -13.9%
6 months -36.7%
1 year -48.3%
3 years 19.2%

Risk

Volatility (1y ann.) 77.0%
Beta vs ASX 200 0.19
Sharpe (1y) -0.52
VaR 95% (1-day) -9.1%
Max drawdown (1y) -61.3%
Off 1-year high -58.7%

Technicals

RSI(14) 30
vs 50DMA -5.6%
vs 200DMA -30.8%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 62.5
Trailing P/E
100
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
0
Price / Sales
0
Growth —
Revenue growth (1y)
—
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
—
Quality (Profitability & Cash Flow) 54.5
Return on equity
100
Return on assets
0
Operating margin
0
Net margin
100
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 5.5
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
22
Position in 52-week range
4

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$6.65M
P/E (trailing)
1.55
P/E (forward)
—
EPS (trailing)
0.02
Dividend yield
—
Payout ratio
0.0%
Beta
-0.34
EV / EBITDA
0.06
Price / Book
31.00
ROE
157.5%
Operating margin
-200,395.8%
Net margin
755,566.9%
Total cash
$6.74M
Total debt
$0
Current ratio
13.87
Debt / Equity
—
Free cash flow
$-685,896
Avg volume
46,009
Latest annual results (FY ending 30 Jun 2024)
  • Revenue—
  • Gross profit—
  • Operating income-$1.51M
  • Net income-$1.59M
  • Diluted EPS-0.01
  • Free cash flow-$1.17M
  • Net debt-$1.71M
Sector peers (Basic Materials)
TickerMkt cap P/EScore
BHP $311.13B 22.0 68.1
RIO $268.04B 15.5 58.1
NEM $174.41B 14.5 82.2
FMG $49.85B 12.1 60.7
NST $34.22B 20.7 76.0
EVN $26.76B 17.9 79.4
S32 $22.08B 14.5 67.1
JHX $20.94B 112.7 45.6